Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial-Reference-Cited by-同舟云学术

Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial

Published:2018-09-27 Issue: Volume:9 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Verschuur Arnauld,Heng-Maillard Marie-Amélie,Dory-Lautrec Philippe,Truillet Romain,Jouve Elisabeth,Chastagner Pascal,Leblond Pierre,Aerts Isabelle,Honoré Stéphane,Entz-Werle Natasha,Sirvent Nicolas,Gentet Jean-Claude,Corradini Nadège,André Nicolas

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference32 articles.

1. Metronomic chemotherapy and radiotherapy as salvage treatment in refractory or relapsed pediatric solid tumours.;Ali;Curr. Oncol.,2016

2. Pilot study of a pediatric metronomic 4-drug regimen.;André;Oncotarget,2011

3. Has the time come for metronomics in low-income and middle-income countries?;André;Lancet Oncol.,2013

4. For cancer, seek and destroy or live and let live?;André;Nature,2009

5. Metronomical etoposide/cyclophosphamide/celocoxib regimen given to children with refractory cancer: a preliminary monocentric study.;André;Clin. Pharm.,2008

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metronomic chemotherapy in pediatric neurooncology: insight the problem. A review;Journal of Modern Oncology;2024-07-03

2. Chemotherapy in pediatric low-grade gliomas (PLGG);Child's Nervous System;2024-05-31

3. Retrospective experience of children with relapsed brain tumors treated with oral combination of axitinib and metronomic etoposide;Pediatric Blood & Cancer;2024-05-22

4. Metronomic Chemotherapy for Pediatric Refractory Solid Tumors: A Retrospective Single-Center Study;Journal of Pediatric Hematology/Oncology;2024-04-29

5. METRO-PD1: Phase 1 study of nivolumab in combination with metronomic chemotherapy in children and adolescents with relapsing/refractory solid tumors;European Journal of Cancer;2024-02